JESSIE BLACKMON: Open Payments
NPI 1811460173 · VESTAVIA HLS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,346 in 53 payments from 13 companies in 2025. Trend: 2023 $348 · 2024 $1,459 · 2025 $1,346
Food & beverage: $1,194Education: $152
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $427 |
| Amgen Inc. | 11 | $245 |
| ABBVIE INC. | 13 | $196 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $119 |
| Lilly USA, LLC | 1 | $92 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| GENZYME CORPORATION | 3 | $51 |
| Organon LLC | 4 | $43 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
Products named: TREMFYA, Otezla, SKYRIZI, DUPIXENT, Cabtreo, EBGLYSS, COSENTYX, SPEVIGO.
Industry payments across AL — which companies pay providers there.
